Opinion statement Considerable advances in the investigation and management of
oesophagogastric cancer have occurred over the last few decades. While the historically …

Background Immune checkpoint inhibitors are increasingly used in neoadjuvant therapy for
locally advanced gastric cancer. However, the effect of body composition on the efficacy of …

Background Sarcopenic obesity (SO) affects outcomes in various malignancies. However, its
clinical significance in patients undergoing neoadjuvant chemotherapy (NAC) for locally …

Background The association between body composition and survival in rectal cancer
patients is still unclear. Therefore, we aimed to evaluate the impact of computed tomography …

Background To explore the impact of body composition before neoadjuvant
chemoradiotherapy (pre-NCRT) and after neoadjuvant chemoradiotherapy (post-NCRT) on …

Background Research studies on gastric cancer have not investigated the combined impact
of body composition, age, and tumor staging on gastric cancer prognosis. To address this …

Aim To investigate whether body composition parameters combined with systemic
inflammatory markers and magnetic resonance imaging (MRI) can predict the pathological …

Background Recent studies have revealed that sarcopenia is associated with postoperative
complications and poor prognosis. Although neoadjuvant chemotherapy is a promising …

Background The postoperative impact of short‐term changes in skeletal muscle loss (SML)
and adipose tissue loss (ATL) on treatment outcomes is unclear in patients with gastric …

Background: The purposes of neoadjuvant chemotherapy are to tumor size to improve the
tumor removal rate, extend survival, and prevent metastasis. In this study, the importance of …